COVID-19 Update

COVID-19 has imposed an unsettling situation upon our community and our business, but at Cleveland Diabetes Care and our affiliates, KRS Global Biotechnology and Complete Pharmacy Medical Solutions, we are committed to fighting back the best way we know how. By providing better medicine for better lives we will continue operations that include creation and distribution of life saving medications and testing kits to all reaches of our great nation.

KRS Global Blog

22

July
2016

category:

503b Compounding

KRS Spotlighted in the BDB’s Profile Magazine

KRS is honored to be a part of the Palm Beach County business community.  The support that the city, county and state have show us is truly amazing!  Check out the link to the article:  https://issuu.com/passportpublications/docs/profile_2016/1 Contact us today to get more information about KRS or to join the team!

read more

13

July
2015

category:

503b Compounding

FDA Finalizes Six-Month Drug Shortage Notice Regulation

From the Regulatory Affairs Professionals Society (RAPS) June 8, 2015 By Michael Mezher A regulation proposed by the US Food and Drug Administration (FDA) in 2013 will take effect on 8 September, requiring drug and biologics manufacturers to notify the agency in advance of impending drug shortages. Background In 2011, after several years of worsening […]

read more

24

June
2015

FDA Releases New Guidance for Compounding Animal Drugs from Bulk Drug Substances

June 24, 2015 Animal Compounders Fear the End is Near & Begin to Fight Their Losing Battle A few weeks ago the FDA released their latest guidance, #230 Guidance for Industry Compounding Animal Drugs from Bulk Drug Substances and animal compounders are very concerned at what this means for their futures. All guidances reflect the […]

read more